New Times,
New Thinking.

  1. Chart of the Day
24 February 2022

Russian stocks plummet as troops enter Ukraine

The benchmark MOEX Russia Index fell by 45 per cent this morning.

Russian equities had their biggest drop in value on record today (24 February) as Russian forces attacked Ukraine from the north, south and east, with missile strikes reported near major cities.

The MOEX Russia Index was down around 45 per cent this morning, and the RTS Index lost 50 per cent of its value, before both rebounded slightly.


The rouble also took a hit, falling to its lowest-ever value against the dollar, at $0.0111, while gas and oil prices rose dramatically. Russia is the world’s second largest oil producer and sells most of its crude to Europe. Brent crude was at $105 a barrel at the time of writing – the highest level since 2014.

European financial stocks also dropped, particularly European banks with big operations in Russia, as further sanctions on Russia became almost a certainty. An index of European banking stocks was down 6.1 per cent before midday.

Aluminium prices have risen (Russia is a major metals producer), and wheat prices surged (Russia and Ukraine are both giant global wheat producers, accounting for more than a quarter of global exports between them).

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines

Topics in this article :